Initial Treatment for Alcoholic Hepatitis
Assessment of Disease Severity
- The American Association for the Study of Liver Diseases recommends evaluating disease severity using validated scoring systems, including Maddrey discriminant function (MDF) >32, MELD score >20, Glasgow alcoholic hepatitis score of 9, and ABIC score category C, to guide treatment decisions 1, 4
- The American College of Gastroenterology suggests that all patients should be screened for infections regardless of fever presence, with cultures of blood, urine, and ascites (if present) 1, 4
First-Line Interventions
- The American College of Gastroenterology recommends complete abstinence from alcohol as essential for treatment, as continued alcohol use leads to disease progression and worsens outcomes 1, 2
- The European Association for the Study of the Liver suggests providing high-calorie, high-protein diet: 30-40 kcal/kg/day and 1.2-1.5 g/kg/day protein 1, 6
Treatment Based on Disease Severity
- For severe alcoholic hepatitis (MDF ≥32, MELD >20), the American Association for the Study of Liver Diseases recommends corticosteroid therapy with prednisolone 40 mg daily for 28 days (followed by discontinuation or 2-week taper) 2, 3
- The American College of Gastroenterology suggests assessing response to steroids at day 7 using the Lille model or Early Change in Bilirubin Level (ECBL), with Lille score <0.45 indicating good response (85% 6-month survival) and Lille score >0.45 indicating poor response (25% 6-month survival) 1, 3
Special Considerations
- The American College of Gastroenterology recommends avoiding nephrotoxic drugs, including diuretics, as acute kidney injury is an early manifestation of multi-organ failure 1
- The European Association for the Study of the Liver suggests using caution with iodinated contrast agents for imaging, as they increase the risk of acute kidney injury 1
Monitoring Response
- The American Association for the Study of Liver Diseases recommends evaluating response to treatment at day 7 using the Lille model or ECBL 3
- The American College of Gastroenterology suggests monitoring for infections, which can develop after initial diagnosis and are associated with high mortality 1